EGF and non-small cell lung carcinoma: Significantly, PPI exhibited an inhibitory effect on epidermal growth factor (EGF) receptor tyrosine kinase inhibitors, which has a mutagenic and pro-EMT action in non-small cell lung cancer (Lou et al., 2017).